Gene: CLUAP1
Official Full Name: clusterin associated protein 1provided by HGNC
Gene Summary: The protein encoded by this gene contains a single coiled-coil region. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Jul 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29953 | CLUAP1 Knockout cell line (HeLa) | Human | CLUAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO29954 | CLUAP1 Knockout cell line (HCT 116) | Human | CLUAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO29955 | CLUAP1 Knockout cell line (HEK293) | Human | CLUAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO29956 | CLUAP1 Knockout cell line (A549) | Human | CLUAP1 | 1:3~1:4 | Negative | Online Inquiry |
CLUAP1 Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the CLUAP1 gene, which encodes a crucial protein involved in cellular processes such as cytoskeletal dynamics and mitochondrial function. The knockout of the CLUAP1 gene facilitates the study of its role in various biological contexts, particularly in the realms of cell signaling, development, and disease pathogenesis. These cell lines serve as powerful tools for researchers to investigate the implications of CLUAP1 loss in disease models, particularly in cancer and neurodegenerative disorders.
The key functions of CLUAP1 include its involvement in the stabilization of microtubules and regulation of cellular motility. By eliminating the CLUAP1 gene, users can observe altered cell morphology, migration patterns, and intracellular signaling pathways, thereby providing insights into the gene’s contributions to health and disease. This unique approach allows for a more nuanced understanding of the gene’s biological implications, which can be pivotal in unraveling complex disease mechanisms.
From a scientific perspective, the CLUAP1 Gene Knockout Cell Lines hold significant value in various research and clinical settings. They offer a platform for drug discovery, enabling the identification of novel therapeutic targets and the assessment of drug efficacy in conditions marked by dysregulated CLUAP1 activity. Furthermore, they can be utilized to develop gene therapies aimed at restoring normal function in diseases associated with CLUAP1 loss.
What sets our CLUAP1 Gene Knockout Cell Lines apart is their rigorous validation and quality control processes, ensuring high reproducibility and reliability in experimental settings. Unlike other alternatives that may not provide comparable specificity or genetic accuracy, our cell lines are developed using state-of-the-art CRISPR/Cas9 technology. This precisely targeted approach allows researchers to be confident in the results generated, making our products an indispensable asset in advancing scientific knowledge.
In conclusion, the CLUAP1 Gene Knockout Cell Lines represent a cutting-edge resource for researchers and clinicians seeking to explore the genetic underpinnings of health and disease. Our company, with its commitment to excellence and innovation in biological products, provides not only robust research tools but also the expertise necessary to support users in their investigative endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.